Introduction
Insulin secretion from pancreatic β-cells is highly regulated by complex signaling pathways upon stimulation by glucose and other fuels, and by multiple hormones and neurotransmitters (21;33;45) . It is known that secretagogue-induced insulin secretion is mediated by a series of metabolic coupling factors (such as ATP/ADP ratio), second messengers (Ca 2+ , cAMP) and regulators (e.g. protein kinases, inositol phospholipids and GTP-binding proteins) (10;21;33;37;53;63) . The exocytotic process is regulated at several stages, including transport of granules toward the plasma membrane, granule docking, priming, and finally fusing with the plasma membrane (58) . It is well established that an increase of cytosolic fee Ca
2+ concentrations ([Ca
] i ) is one of the signals for exocytosis. However, this process also involves other proteins such as SNAREs and may be regulated by GTP and/or GTP-binding proteins (13;25;27;33;61) . In many secretory systems including insulin-secreting cells,
GTPγS is able to induce secretion independent of Ca 2+ , suggesting that GTP/G-proteins may exist as a parallel pathway for the regulated exocytosis (33;47). Indeed, it has been reported that the GTP-binding protein rab3 stimulates release of neurotransmitters and hormones from permeabilized cells including islet β-cells (15;37).
The Rho family of small GTP-binding proteins is a subfamily of Ras-related superfamily and that the cortical actin cytoskeletal web acts as a barrier to hamper the access of secretory granules to the plasma membrane and a reorganization of F-actin in this region occurs during late steps of exocytosis. In pancreatic β cells, disrupting F-actin by cytochalasin B facilitated insulin release (28), in particular, the first phase of insulin secretion (39) . On the other hand, maintenance of F-actin structure is also required for secretory process. For instance, an increase of F-actin was observed when pancreatic β cells were stimulated by glucose (57) , and cholecystokinin-induced exocytosis in permeabilized pancreatic acinar cells was inhibited when the highly concentrated monomeric actin-binding protein β-thymosin was introduced (43) . Moreover, disruption of F-actin filaments by using Clostridium botulinum C2 toxin preferably reduced the second phase of insulin secretion from islet β-cells (39) .
Thus, the basic substructure of actin cytoskeleton may also be essential for the normal recruitment of secretory granules to the plasma membrane. In addition, actin network may provide contractile forces that expel the granule contents (60) , since earlier studies have demonstrated that inhibition of myosin light chain kinase reduced insulin secretion from β-
cells (39).
The members of Rho family proteins which may participate in the regulation of exocytosis through controlling reorganization of cytoskeleton or other processes are still uncertain. It appears, however, that Rac proteins are particularly interesting in this context as evidenced in several secretion systems, including mast cells, chromaffin cells and neuronal cells (8;11;17;30;48) . At least three Rac isoforms have been identified in mammals. Rac1 is ubiquitously expressed (18;42) , while Rac2 is a hematopoietic-specific and Rac3 is highly expressed in brain (18;56) . It was found that constitutively-active Rac enhanced regulated secretion whereas dominant-negative Rac exhibited opposite effects in permeabilized mast cells (8;48) . Our previous study using clostridial toxins to specifically inactivate certain members of Rho proteins in pancreatic β cells also implies that Rac and Cdc42 rather than Rho may be the candidate regulators implicated in stimulated insulin secretion (31).
In the present study we provided the evidence, for the first time, for the activation of Rac1 following glucose stimulation in insulin-secreting cells as demonstrated by the translocation of Rac1 from cytosol to the membranes (including plasmalemma). Importantly, insulin release stimulated by glucose alone or plus forskolin was significantly reduced in ß cells expressing dominant-negative Rac1. This inhibitory effect was more obvious on the sustained phase of insulin secretion, indicating that Rac1 might be involved in the recruitment of secretory granules by maintaining, at least in part, the F-actin structure in the interior of cytoplasm. Our results also suggest that cAMP and protein kinase A (PKA) may facilitate exocytosis of insulin via a mechanism dependent on the functional activation of Rac1.
Materials and Methods

Plasmids
The plasmids containing human Rac1 mutants (pEXVV12rac and pEXVN17rac) were generously provided originally by Dr. Allan Hall, University College of London, UK. These two plasmids were constructed by cloning the dominant-negative form N17Rac1 (substitution of threonine 17 by asparagine) and the constitutively active form V12Rac1 (replacement of glycine 12 by valine) into vector pIREShyg1 (Clontech, Palo Alto, CA, USA); the N-terminal of these Rac1 mutants was tagged with c-Myc as a mark which can be recognized by an antiMyc antibody. A plasmid containing wild type Rac1 was also generated in the similar way. following protease inhibitors: leupeptin (10 µg/ml), aprotinin (4 µg/ml), pepstatin (2 µg/ml) and PMSF (100 µM). The cells were then disrupted by 10 strokes through a 27G needle. The cell homogenates were centrifuged at 900 g for 10 min to remove the nuclei and unbroken cells. Mitochondria-enriched, secretory-granule-enriched and microsomal fractions were isolated by centrifuging post-nuclear supernatants at 5,500 g for 15 min (in Eppendoff 5417R), 25,000 g for 20 min and 100,000 g for 60 min (in Beckman L-80), respectively. For the isolation of total membrane and soluble fractions, the post-nuclear supernatants were centrifuged at 100,000 g for 60 min. The purity of isolated subcellular fractions from INS-1 cells was extensively assessed in our previous study (35) by analyzing the specific biochemical markers of organelles (cytochrome c for mitochondria, aryl sulphatase for lysosomes, insulin for secretory granules, NADPH reductase for ER, and 5'-nucleotidase for the plasma membrane) for each of the fractions as well as by electron microscopy examination.
Isolation of the plasma membrane was carried out following a protocol by Hubbard et al (26) , which generates a highly purified plasma membrane fraction with only 4.6%, 1.5% and 20%
of contamination from mitochondria, lysosomes and ER, respectively. In brief, the cell homogenates were centrifuged at 280 g for 5 min to remove the nuclei and unbroken cells. 
Measurement of Rac1 GTPase activity
Rac1 activity was determined by a pull-down assay using GST-PAK-CD (CD denotes to CRIB domain) as a probe that solely binds to active Rac1-GTP and Cdc42-GTP (40) . INS-1 cells (~1 x 10 7 ) were incubated with 2.8 mM or 15 mM glucose for 30 min. The cells were then washed with ice-cold PBS and incubated for 5 min on ice in 1 ml lysis buffer (50 mM Tris-HCl, pH 7.4, 30mM MgCl 2 , 1% Triton X-100, 10% glycerol, 100 mM NaCl, 1 mM DTT, 1 µg/ml leupeptin, 1 µg/ml pepstatin, and 1 µg/ml aprotinin). Cells were harvested by lifter and centrifuged for 5 min at 21,000 g at 4°C. Aliquots (100 µl) were taken from the supernatant for detecting total Rac1 amount. The remaining supernatants were incubated with 20 µg GST-PAK-CD fusion peptide (a generous gift from Dr. Edward Manser, Institute of Molecular and Cell Biology, Singapore) and 25 µl 50% glutathione-Sepharose 4B beads (Amersham, UK) for 60 min at 4 °C with gentle agitation. The mixture was centrifuged at 500 g for 5 min to sediment the matrix, followed by 3 washes with cold lysis buffer. The proteins were eluted by adding Lammili sample buffer and boiled for 5 min. The eluted samples, including those supernatant aliquots, were subjected to SDS-PAGE and Western blotting as described above.
Observation of cell morphology INS-1 cells were cultured in coverslip chambers (LAB-TEK, Nalge Nunc International Corp., Naperville, IL, USA) for 2-4 days. Living cell morphology was examined under differential interference contrast (DIC) by laser confocal microscopy.
Assessment of F-actin filaments F-actin staining by phalloidin toxin was conducted as described previously (39) . INS-1 cells were seeded on glass coverslips and cultured for 2 days. After 2 washes with PBS (pH 7.4), cells on coverslips were fixed with 3.7% paraformaldehyde in PBS for 10 min. Cells were washed twice again and then incubated with 330 nM rhodamine-phalloidin (Molecular Probes, USA) and 300 ng/ml of lysophosphatidylcholine (Sigma, USA) for 20 min at room temperature. Subsequently, coverslips were washed twice with cold PBS and mounted on glass slides. The slides were examined by laser confocal microscopy.
Measurements of insulin secretion
Insulin secretion was determined as described previously (3; ] i ) were determined by the fluorescent probe fura-2 as described in details previously (36) .
Statistical analysis
Data were expressed as mean ± SEM and statistically analyzed by two-tail t-test.
Results
Differential distribution of expressed Rac1 mutants compared to endogenous Rac1
In control INS-1 cells, the endogenous Rac1 was mainly present in cytosol even though trace amounts were detected in the fractions enriched with mitochondria and secretory granules as assessed by Western-blotting (Fig. 1A, left) . Immunofluorescence staining indicated that native Rac1 is distributed in whole cytoplasm (Fig. 1A, right ).
An antiserum recognizing exclusively Myc-taged proteins was employed for immunofluorescence staining of Rac1 mutants. No signal could be detected in control cells (additional data not shown). Although the staining in dominant-negative N17Rac1 transfected cells was observed primarily in the soluble compartment, considerable staining patterns were also detected around the cell periphery (Fig. 1B, left) . The constitutively-active V12Rac1 was more evenly distributed in the cells (Fig. 1B, right) . Western blot analysis revealed that N17Rac1 was primarily detected in fractions enriched with mitochondria or insulincontaining secretory granules (Fig. 1C, lane 1) , while V12Rac1 was distributed in all fractions including the microsomal and cytosolic fractions (Fig. 1C, lane 3) .
Glucose specifically stimulates translocation of Rac1 from cytosol to membranes in control, but not in cells expressing the mutated Rac1
When control INS-1 cells were stimulated by 15 mM glucose for 30 min, there was an increase of Rac1 in the membrane fraction with a concomitant reduction in cytosol (Fig. 2B ).
Relative abundance of Rac1, expressed as its membrane to cytosolic ratio, was significantly increased (1.57 fold; from 0.19 ± 0.02 to 0.49 ± 0.04) following exposure to stimulatory concentrations of glucose ( Fig. 2A) . The cAMP-elevating agent forskolin (1 µM) did not significantly affect the degree of Rac1 translocation elicited by glucose. Such glucoseinduced Rac1 translocation effect reached significance at 15 min (Fig. 2C) . Further studies revealed that 15 mM glucose is able to specifically facilitate translocation of Rac1 into the plasmalemma fraction from the cytosol (Fig. 3) . Importantly, activation of Rac1 by glucose was confirmed by the direct detection of Rac1 GTPase activity. Using a fusion peptide (GST-PAK-CD) that is solely bound to the activated Rac1 (GTP-Rac1) as a probe (40), we have been able to demonstrate that 15 mM glucose significantly increased GTP-bound Rac1 (i.e.
elevation of Rac1 activity) in control INS-1 cells over 30 min stimulation (Fig. 4) .
In contrast, stimulation by glucose plus forskolin for 30 min did not alter Rac1 distribution between cytosol and membranes in either Rac1 mutant transfected cells (Fig. 1C , lanes 2 and 4), when probed with an antibody that recognized solely the Myc-taged Rac1 mutants.
Interestingly, even though the basal levels of membrane-associated total Rac1 were higher by 32% and 62% in N17Rac1-and V12Rac1-transfected cells, respectively (assessed by an antibody that recognized both endogenous Rac1 and transfected Rac1 mutants), further stimulation of these cells by glucose failed to increase Rac1 association with the membranes (Fig. 2) , including plasmalemma (Fig. 3 ). In addition, no apparent difference could be observed in the total Rac1 (both endogenous and mutated) content between control and the two Rac1 mutant-transfected cells (data not shown).
Expression of dominant negative Rac1 significantly alters the morphology and causes disruption of F-actin filaments in INS-1 cells
The control INS cells grew in monolayer on the culture surface with substantial lamellipodia (Fig. 5A ). Remarkable changes in morphology occurred in N17Rac1-transfected cells, which had less lamellipodia (a known morphological marker of Rac function (19) ) and tended to aggregate and stack (Fig. 5B ). These cells rounded up and their ability to adhere to the substratum was also weaker since they were more easily detached by trypsinization. Besides, the size of these cells was significantly smaller (diameter of 9.9 vs. 12.6 nm of control cells) in suspensions. By contrast, INS-1 cells expressing the V12Rac1 only revealed slight morphological changes, including more protrusions (Fig. 5C ). In addition, these cells were more resistant to trypsinization. These observations indicate that active Rac1 may be important for INS-1 cells to maintain normal morphology.
The observed morphological changes might be due to the interference with cytoskeleton organization in the transfected cells. Control INS-1 cells displayed strong F-actin distribution in cell periphery and also some filaments in the interior of cells, as assessed by rhodaminephalloidin staining (Fig. 5D) . By contrast, F-actin staining in N17Rac1 transfected cells almost completely disappeared (Fig. 5E ). Despite some modest degree of reduction of F-actin staining in V12Rac1 transfected cells, structure of F-actin filaments remained largely intact in these cells (Fig. 5F ). These findings suggest that the organization of F-actin filaments in INS-1 cells requires functional Rac1.
Expressing dominant-negative N17Rac1 inhibits insulin secretion in INS-1 cells
Stable expression of dominant-negative or -active Rac1 mutants did not alter either the insulin content in INS-1 cells (Table 1) or the basal insulin secretion rate (Fig. 6 ). Insulin secretion from control cells over 30 min was increased by 90% following exposure to 15 mM glucose and by >2.9 fold when simultaneous incubation with glucose and forskolin (Fig. 6 ).
Expression of dominant-negative N17Rac1 significantly inhibited glucose-induced (>50%) and glucose plus forskolin -induced (60%) insulin secretion (Fig. 6 ). However, insulin release induced by glucose alone or glucose plus forskolin was not significantly affected in cells expressing constitutively-active V12Rac1. In addition, high potassium-stimulated secretion was not significantly affected in cells transfected with either of the Rac1 mutants (Fig. 6) . Furthermore, stable expression of wild type Rac1 (Fig. 7A ) also did not alter secretagogues-induced insulin release (Fig. 7B ) and morphology of these cells remained unchanged (data not shown), suggesting the specific N17Rac1 effects due to interference with Rac1. These data indicate that Rac1 may be involved in glucose and forskolin stimulated insulin secretion from INS-1 cells.
It is well known that glucose evokes biphasic pattern of insulin secretion from islet β-cells and each of the two phases are felt to be controlled by different mechanisms (7;21;53). To determine the possibly distinct roles of Rac1 in the two phases, we measured insulin secretion from the dominant-negative Rac1 transfected cells during two consecutive static stimulating periods (initial 15 min as the early secretion event and followed by a 20 min incubation reflecting the late (sustained) secretion event), an approach used previously to study the early and late phase insulin secretion responses to glucose in isolated islets (44). The potentiating effect of forskolin on glucose-stimulated insulin secretion was greater (by 165%) during the late period than the early phase (by 101%) in the control cells (Fig. 8) . In cells expressing N17Rac1, the early phase of insulin release stimulated by glucose plus forskolin was significantly inhibited (-42%), albeit without significant effect on the release elicited by glucose alone (Fig. 8A) . Furthermore, the degree of insulin secretion induced by either glucose alone or plus forskolin during the late period was markedly inhibited by 63% and 49%, respectively (Fig. 8B) . These results implicate that functional activation of Rac is essential for the late phase of insulin release, an effect that may be related to the Rac1 translocation and activation by glucose during this period (cf. Fig. 2C ). suggesting that the very distal steps in secretory machinery remain largely intact. The disappearance of F-actin filaments in these cells indicated that F-actin fibers may be necessary for the recruitment of secretory granules to the plasma membrane for exocytosis.
Earlier studies from our laboratory (31;32) and by others (9) There is strong evidence that Rac is a key control element in the reorganization of actin cytoskeleton (19) . Microinjection of V12Rac was capable of inducing lamellipodia and membrane ruffle as well as subsequent stress fiber formation, whereas injection of N17Rac abolished these effects in fibroblasts (52). Thus it is not surprising that the morphology of β-cells would be altered by interference with Rac function. The morphological changes in our Rac1 mutants-transfected cells were accompanied with the alterations of F-actin distribution.
F-actin filaments almost completely disappeared in N17Rac1-transfected cells and these cells were rounding-up. Surprisingly, expression of constitutively-active Rac1 mutant did not enhance the formation of actin cytoskeleton as in other cell types (52), rather had a small opposite effect. Importantly, F-actin structure may be also involved in the transport of secretory granules, since loss of these F-actin filaments in N17Rac1-transfected cells displayed preferred inhibition of the late phase of stimulated insulin secretion. Our earlier study using Clostridium botulinum C2 toxin to disrupt F-actin structure also found a more severe inhibition of the second phase of insulin secretion in HIT-T15 cells and in isolated rat islets (39) . Together, these findings suggest that the role of Rac1 in regulated insulin secretion may involve the regulation of actin cytoskeleton reorganization for secretory granule recruitment which is required for the second phase of secretion (24;39).
One should be aware of the possible non-specific effects due to overexpression of a protein in transfection experiments. However, three lines of evidence suggested that such an effect was minimal or unlikely in our study. First, overexpression happens frequently in transient transfection. In our case, stable transfection was performed and it did not produce overexpression, since the total amount of Rac1 (endogenous plus mutant) in the homogenates of either Rac1 mutant-transfected cells was no difference from that of control cells. Second, we only observed marked alterations of insulin secretory response, cell morphology and Factin cytoskeleton in cells transfected with N17Rac1, but not V12Rac1, suggesting a specific effect of the former. Third, stable expression of wild type Rac1 had no effect on morphology and secretagogues-induced insulin release in INS-1 cells.
Our data indicate that Rac1 may also be involved in the cAMP-modulated insulin secretory pathway. It is well known that protein kinase A (PKA) activation by cAMP can positively influence regulated secretion in many cell systems, including the islet ß cell. We observed that forskolin potentiated both early and late phase insulin secretion but that this effect was more significant on the late secretion event. It has been reported that PKA can regulate Rac1- Rest membrane potential (% maximal effect) 62.9 ± 1.1 (6) 61.6 ± 2.1 (6) 64. observations. * P<0.05 vs. control. The stained cells were examined by laser confocal microscopy. Bar = 20 µm. 
